TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7926977

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (r‐EPO) administered subcutaneously at dosages up to 1050 U/kg a week for at least two months
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (r‐EPO)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal controls (N=42)
Number of subjects: 26
Study: 2512637

Group type: EXPERIMENTAL
Intervention: tenoxicam 20 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: piroxicam 20 mg daily
Number of subjects: 20
Study: 1105630

Group type: EXPERIMENTAL
Intervention: Secobarbital (100 mg)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Secobarbital (130 mg)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: CPZ (0.667 and 1.334 mg/kg)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Diazepam (0.071, 0.142, and 0.284 mg/kg)
Number of subjects: 1
Study: 29479829

Group type: EXPERIMENTAL
Intervention: Savoring writing task
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control writing task
Number of subjects: 271
Study: 27109623

Group type: EXPERIMENTAL
Intervention: Verucerfont (350 mg per day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 24703529

Group type: EXPERIMENTAL
Intervention: tDCS 2mA
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: tDCS 1mA
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18
Study: 21994343

Group type: EXPERIMENTAL
Intervention: Active snus
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo snus
Number of subjects: 250
Study: 20174998

Group type: EXPERIMENTAL
Intervention: Remote electronic tool
Number of subjects: 135

Group type: COMPARATOR
Intervention: Face-to-face time trade-off
Number of subjects: 135
Study: 18285429

Group type: EXPERIMENTAL
Intervention: Minimal acupuncture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Chinese medical acupuncture
Number of subjects: 14
Study: 16503881

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (usual care with emollients and topical corticosteroids)
Number of subjects: 0
Study: 12788302

Group type: EXPERIMENTAL
Intervention: Repeat fibrinolytic therapy
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Aggressive treatment (repeat fibrinolysis or urgent revascularization)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Death within 24 h of reinfarction
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: 1-year mortality
Number of subjects: 670
Study: 11707834

Group type: COMPARATOR
Intervention: CHOP (3 courses)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: ESHAP followed by HDT and PBPCT
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: ESHAP/HDT
Number of subjects: 58

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 58
Study: 8610234

Group type: EXPERIMENTAL
Intervention: Vinorelbine plus cisplatin
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Vindesine plus cisplatin
Number of subjects: 612
Study: 2058576

Group type: COMPARATOR
Intervention: 0% lactose milk
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50% lactose-reduced milk
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80% lactose-reduced milk (#1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80% lactose-reduced milk (#2)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 95% lactose-reduced milk
Number of subjects: 6
Study: 6845046

Group type: EXPERIMENTAL
Intervention: Benzoylmetronidazole 50 ml (2 g metronidazole equivalent) as a single dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated group (Trichomonas vaginalis infection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients free of Trichomonas vaginalis infection)
Number of subjects: 0
Study: 30173286

Group type: EXPERIMENTAL
Intervention: Bioenterics intragastric balloon – Orbera + VLCKD (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Orbera + LCD (n = 40)
Number of subjects: 80
Study: 26892080

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with stenting (n = 52)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG) (n = 53)
Number of subjects: 105
Study: 25315942

Group type: EXPERIMENTAL
Intervention: Esmolol (β-blocker)
Number of subjects: 41
Study: 22755276

Group type: EXPERIMENTAL
Intervention: IFN-gamma
Number of subjects: 44

Group type: COMPARATOR
Intervention: Amantadine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: IFN-gamma (relapsers)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Amantadine (relapsers)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: IFN-gamma (non-responders)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Amantadine (non-responders)
Number of subjects: 44
Study: 20798393

Group type: EXPERIMENTAL
Intervention: Difluoromethylornithine (eflornithine)/sulindac
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 18160923

Group type: EXPERIMENTAL
Intervention: Acupuncture needling
Number of subjects: 39

Group type: COMPARATOR
Intervention: 0.5% lidocaine injection
Number of subjects: 39
Study: 16359984

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (200 microg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12169967

Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 36
Study: 10670862

Group type: EXPERIMENTAL
Intervention: Eversion carotid endarterectomy (ECEA)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Open carotid endarterectomy with primary closure (CEA)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Open carotid endarterectomy with patch closure (CEAP)
Number of subjects: 190
Study: 7587688

Group type: EXPERIMENTAL
Intervention: Preoperative parenteral nutritional support (PNS) for 7 days in addition to oral intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative parenteral nutritional support (PNS)
Number of subjects: 0
Study: 2181127

Group type: EXPERIMENTAL
Intervention: Physiotherapy and disease education
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 53
Study: 43488

Group type: EXPERIMENTAL
Intervention: Oxprenolol (300 mg daily for 8 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oxprenolol combined with clortalidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oxprenolol combined with phentolamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Beta-blocking agents alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined administration of oxprenolol and clortalidone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined administration of oxprenolol and phentolamine
Number of subjects: 30
Study: 31135570

Group type: EXPERIMENTAL
Intervention: VYC‐25L hyaluronic acid injectable gel
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (received VYC‐25L 3 months later)
Number of subjects: 119
Study: 26938764

Group type: EXPERIMENTAL
Intervention: Dexamethasone with bupivacaine (8 mg dexamethasone mixed with 18 mL of 0.25% bupivacaine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine with placebo (18 mL of 0.25% bupivacaine and 2 mL of 0.9% saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexamethasone with bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine with placebo
Number of subjects: 60
Study: 25543972

Group type: EXPERIMENTAL
Intervention: Continuous infusion furosemide
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 427

Group type: COMPARATOR
Intervention: High-dose diuretic therapy
Number of subjects: 427

Group type: COMPARATOR
Intervention: Low-dose diuretic therapy
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Baseline log PRA
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Baseline log aldosterone
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Change in RAAS biomarkers from baseline to 72 and 96 h
Number of subjects: 427
Study: 23841261

Group type: EXPERIMENTAL
Intervention: Sarcandra glabra (SG) decoction at a daily dose of 20 g
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemoradiotherapy (Control group)
Number of subjects: 100
Study: 21070885

Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) Reveal XT during 3 Tesla MRI
Number of subjects: 24
Study: 19242985

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Anxiety disorder education (ADE)
Number of subjects: 46
Study: 17105880

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 15100562

Group type: EXPERIMENTAL
Intervention: Adherents to stimulant treatment (n = 41)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adherents to stimulant treatment (n = 16)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Medication status at year 2
Number of subjects: 79

Group type: COMPARATOR
Intervention: Adherence status at year 5
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adverse effects of stimulant treatment
Number of subjects: 79
Study: 11687919

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg
Number of subjects: 491

Group type: COMPARATOR
Intervention: Telmisartan 80 mg
Number of subjects: 491
Study: 9219049

Group type: EXPERIMENTAL
Intervention: Improvement of the listening environment
Number of subjects: 0
Study: 8512622

Group type: EXPERIMENTAL
Intervention: Low-dose ethanol (LD)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-dose ethanol (HD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 21
Study: 2852239

Group type: EXPERIMENTAL
Intervention: Reduction of Colles' fractures without anesthesia
Number of subjects: 116

Group type: COMPARATOR
Intervention: Reduction of Colles' fractures with local anesthetic
Number of subjects: 116
Study: 29753420

Group type: EXPERIMENTAL
Intervention: Accelerated strategy
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard strategy
Number of subjects: 268
Study: 28268619

Group type: EXPERIMENTAL
Intervention: Audiovisual BCI system
Number of subjects: 1

Group type: COMPARATOR
Intervention: JFK Coma Recovery Scale‐Revised (JFK CRS‐R)
Number of subjects: 1
Study: 24593810

Group type: EXPERIMENTAL
Intervention: ß‐tricalcium‐phosphate‐particles with a polylactid coating (ß‐TCP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: demineralized bovine bone mineral with 10% collagen covered with a collagen matrix (DBBM‐C/CM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DBBM with 10% collagen covered with an autogenous soft tissue punch graft (DBBM‐C/PG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: spontaneous healing (control)
Number of subjects: 40
Study: 22357026

Group type: EXPERIMENTAL
Intervention: Virtual representation of the self exercising
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Virtual representation of other person exercising
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 30
Study: 20042841

Group type: EXPERIMENTAL
Intervention: Real patient contact (n = 61)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Simulated patient contact (n = 102)
Number of subjects: 163
Study: 18412270

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 308
Study: 17121049

Group type: EXPERIMENTAL
Intervention: TCM syndrome-typing based therapy (TCM-STBT) combined with cyclosporin
Number of subjects: 58

Group type: COMPARATOR
Intervention: All-trans-retinoic acid group (control group)
Number of subjects: 58
Study: 12505967

Group type: EXPERIMENTAL
Intervention: Left-sided DLT Broncho-Cath (Group A)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Torque control blocker Univent (Group B)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Wire-guided Arndt blocker (Group C)
Number of subjects: 64
Study: 11276182

Group type: EXPERIMENTAL
Intervention: Physical therapy interventions with visual biofeedback/forceplate training
Number of subjects: 13

Group type: COMPARATOR
Intervention: Physical therapy interventions without visual biofeedback/forceplate training (Control)
Number of subjects: 13
Study: 9250745

Group type: EXPERIMENTAL
Intervention: Indomethacin (2 x 50 mg for 7 days)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Indomethacin (2 x 50 mg for 14 days)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (4 x 3 Gy)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (1 x 7 Gy)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Single irradiation of 5 Gy
Number of subjects: 685

Group type: COMPARATOR
Intervention: Matched control series
Number of subjects: 685
Study: 8237989

Group type: EXPERIMENTAL
Intervention: Schwarz standard measles vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-titer Edmonston-Zagreb or Schwarz vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unvaccinated children
Number of subjects: 0
Study: 10285532

Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM) variables
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Satisfaction measures
Number of subjects: 174
Study: 29098470

Group type: COMPARATOR
Intervention: Fish meal (FM) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: SBM diet (without Lys or Met supplementation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SBM supplement (SBMS) diet (with Lys and Met supplementation)
Number of subjects: 0
Study: 28548643

Group type: EXPERIMENTAL
Intervention: HDAC-123
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: pegfilgrastim
Number of subjects: 568

Group type: COMPARATOR
Intervention: HDAC-135
Number of subjects: 568
Study: 25697851

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 691

Group type: COMPARATOR
Intervention: Right ventricular pacing
Number of subjects: 691
Study: 23600368

Group type: EXPERIMENTAL
Intervention: Highest dose of rosuvastatin (40 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Add-on statin extended release nicotinic acid (ER-NA)/laropiprant (LRPT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Add-on statin micronized fenofibrate
Number of subjects: 100
Study: 21721969

Group type: EXPERIMENTAL
Intervention: Physical Education Questionnaire (PEQ)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Intervention Questionnaire (IQ)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Food Service Manager Questionnaire (FSMQ)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Classroom Observation (CO)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: School Nutrition Environment Observation (SNEO)
Number of subjects: 327
Study: 18978626

Group type: EXPERIMENTAL
Intervention: Closed‐kinetic chain resistance training (CKCRT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Open‐kinetic chain resistance training (OKCRT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CKCRT
Number of subjects: 14

Group type: COMPARATOR
Intervention: OKCRT
Number of subjects: 14
Study: 16551966

Group type: COMPARATOR
Intervention: Cladribine (2‐CdA) alone
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Cladribine combined with cyclophosphamide (CC)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Cladribine combined with cyclophosphamide and mitoxantrone (CMC)
Number of subjects: 508
Study: 12666705

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment (100 mj, 20 pps, 2.0 W, 120 seconds)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling (maximum power, 120 seconds)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment (2.0 W, 120 seconds)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison between Nd:YAG, CO2, and ultrasonic scaling
Number of subjects: 18
Study: 10892683

Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Videofluoroscopic evaluation of swallowing (VFES)
Number of subjects: 30
Study: 8694299

Group type: EXPERIMENTAL
Intervention: Fenoterol (600 micrograms via metered-dose inhaler, 3 puffs 10 min before induction)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (3 puffs of aerosol containing no medication)
Number of subjects: 45
Study: 29555457

Group type: EXPERIMENTAL
Intervention: NP education plus tablet application (interactive conditional logic program)
Number of subjects: 126

Group type: COMPARATOR
Intervention: NP education alone
Number of subjects: 126
Study: 28623713

Group type: EXPERIMENTAL
Intervention: SVE1 (isometric exercise with sinusoidal vibrations; frequency=20Hz, displacement=3.55±0.54mm)
Number of subjects: 19

Group type: COMPARATOR
Intervention: CON (only isometric exercise)
Number of subjects: 19
Study: 26283035

Group type: EXPERIMENTAL
Intervention: Belagenpumatucel-L
Number of subjects: 532

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study: 23677353

Group type: EXPERIMENTAL
Intervention: 8 mg of rhBMP-2
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2.5 mL of autologous bone
Number of subjects: 40
Study: 21149742

Group type: EXPERIMENTAL
Intervention: Intervention group received a mailing containing a reminder letter, brochure, digital video disc, and a follow-up telephone call.
Number of subjects: 628

Group type: COMPARATOR
Intervention: Usual care control group.
Number of subjects: 628
Study: 18562777

Group type: EXPERIMENTAL
Intervention: Caffeine 2 mg/kg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Caffeine 3 mg/kg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 15828972

Group type: EXPERIMENTAL
Intervention: Concurrent distracting mental activity (e.g., free-associating on a task-irrelevant theme or listening to music)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No concurrent distracting mental activity (control condition)
Number of subjects: 0
Study: 12431943

Group type: EXPERIMENTAL
Intervention: Health-coaches track
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional community placement track (shadowing)
Number of subjects: 0
Study: 10513967

Group type: EXPERIMENTAL
Intervention: Manual traction with the leg draped free
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard fracture table traction
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Manual traction
Number of subjects: 79
Study: 7562338

Group type: EXPERIMENTAL
Intervention: Free gingival grafts on the interproximal regenerated tissue
Number of subjects: 28

Group type: COMPARATOR
Intervention: Coronally positioned surgical flaps over the regenerated tissue
Number of subjects: 28
Study: 1771935

Group type: EXPERIMENTAL
Intervention: 75 mg roxatidine nocte
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6789483

Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition (PN)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard Nutrition (SN)
Number of subjects: 42
Study: 29911496

Group type: EXPERIMENTAL
Intervention: Multicomponent training program (resistance, agility, and coordination exercises focusing on plantar flexor muscles) for 12 weeks (3 days per week)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Multicomponent training program
Number of subjects: 26
Study: 27428446

Group type: EXPERIMENTAL
Intervention: Identification method 1
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Identification method 2
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Identification method 3
Number of subjects: 376
Study: 25828637

Group type: EXPERIMENTAL
Intervention: Test formulation of etoposide
Number of subjects: 18
Study: 24965304

Group type: EXPERIMENTAL
Intervention: Sleep restriction (4 hours time in bed per night for 5 consecutive nights)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Men during sleep restriction
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: African Americans
Number of subjects: 44
Study: 21214708

Group type: EXPERIMENTAL
Intervention: Ketamine 2.2 mg kg(‐1) IV
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Alfaxalone 1 mg kg(‐1) IV
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Alfaxalone
Number of subjects: 42
Study: 19553086

Group type: EXPERIMENTAL
Intervention: Risperidone (3-12 mg/day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Olanzapine (10-20 mg/day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Quetiapine (300-750 mg/day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Aripiprazole (12-30 mg/day)
Number of subjects: 78
Study: 18323223

Group type: EXPERIMENTAL
Intervention: Modified Suan Zao Ren Decoction
Number of subjects: 65

Group type: COMPARATOR
Intervention: Surazepam and Diammonium Glycyrrhizinate (Control)
Number of subjects: 65
Study: 15547527

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11281560

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy (HRT)
Number of subjects: 33
Study: 9337001

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Pyrimethamine-sulphadoxine (PSD)
Number of subjects: 173
Study: 7953993

Group type: EXPERIMENTAL
Intervention: Experimental teeth with plaque index (PI) of 3.0
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Experimental teeth with plaque index (PI) of 2.0
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control teeth (plaque not removed)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Experimental teeth with plaque index (PI) of 1.0 or 0
Number of subjects: 67
Study: 3123223

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 80
Study: 30929507

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 0
Study: 28549453

Group type: EXPERIMENTAL
Intervention: Completion axillary lymph node dissection (ALND)
Number of subjects: 3500

Group type: COMPARATOR
Intervention: No completion axillary lymph node dissection (ALND)
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Completion ALND
Number of subjects: 3500

Group type: COMPARATOR
Intervention: No completion ALND
Number of subjects: 3500